191 related articles for article (PubMed ID: 11996199)
1. Statins and osteoporosis: can these lipid-lowering drugs also bolster bones?
Cruz AC; Gruber BL
Cleve Clin J Med; 2002 Apr; 69(4):277-8, 280-2, 287-8. PubMed ID: 11996199
[TBL] [Abstract][Full Text] [Related]
2. [Stimulation of bone formation by statins].
Komatsu Y; Nakao K
Nihon Rinsho; 2004 Feb; 62 Suppl 2():783-8. PubMed ID: 15035227
[No Abstract] [Full Text] [Related]
3. [The role of mevalonate pathway in osteogenic cells].
Ishimi Y
Nihon Rinsho; 2004 Feb; 62 Suppl 2():779-82. PubMed ID: 15035226
[No Abstract] [Full Text] [Related]
4. Cholesterol-lowering drugs may boost bones.
Vogel G
Science; 1999 Dec; 286(5446):1825-6. PubMed ID: 10610568
[No Abstract] [Full Text] [Related]
5. [Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action].
Yoneda T
Nihon Rinsho; 2002 Mar; 60 Suppl 3():688-95. PubMed ID: 11979970
[No Abstract] [Full Text] [Related]
6. [Anabolic effects of statin and beta-blocker on bone metabolism].
Taguchi M; Takeuchi Y
Clin Calcium; 2004 Dec; 14(12):89-94. PubMed ID: 15577180
[TBL] [Abstract][Full Text] [Related]
7. Statins and bone metabolism.
Horiuchi N; Maeda T
Oral Dis; 2006 Mar; 12(2):85-101. PubMed ID: 16476028
[TBL] [Abstract][Full Text] [Related]
8. The role of statins as potential targets for bone formation.
Garrett IR; Mundy GR
Arthritis Res; 2002; 4(4):237-40. PubMed ID: 12106493
[TBL] [Abstract][Full Text] [Related]
9. [Development of BMP-related drugs].
Kawate H; Ohnaka K; Takayanagi R
Nihon Rinsho; 2005 Oct; 63 Suppl 10():463-6. PubMed ID: 16279683
[No Abstract] [Full Text] [Related]
10. Statins and osteoporosis: a clinical review.
Gonyeau MJ
Pharmacotherapy; 2005 Feb; 25(2):228-43. PubMed ID: 15767237
[TBL] [Abstract][Full Text] [Related]
11. Statins as modulators of bone formation.
Edwards CJ; Spector TD
Arthritis Res; 2002; 4(3):151-3. PubMed ID: 12010563
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of bone formation in vitro and in rodents by statins.
Mundy G; Garrett R; Harris S; Chan J; Chen D; Rossini G; Boyce B; Zhao M; Gutierrez G
Science; 1999 Dec; 286(5446):1946-9. PubMed ID: 10583956
[TBL] [Abstract][Full Text] [Related]
13. HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?
Schlienger RG; Meier CR
Drugs Aging; 2003; 20(5):321-36. PubMed ID: 12696993
[TBL] [Abstract][Full Text] [Related]
14. Effects of statins.
Reynolds TM; Wierzbicki AS
Lancet; 2000 Sep; 356(9236):1195. PubMed ID: 11030324
[No Abstract] [Full Text] [Related]
15. HMG CoA reductase inhibitors and the skeleton: a comprehensive review.
Bauer DC
Osteoporos Int; 2003 Jun; 14(4):273-82. PubMed ID: 12736772
[TBL] [Abstract][Full Text] [Related]
16. [Statins and osteoporosis].
Svejda P
Vnitr Lek; 2006 Dec; 52(12):1190-3. PubMed ID: 17299913
[TBL] [Abstract][Full Text] [Related]
17. The role of statins in the differentiation and function of bone cells.
Chamani S; Liberale L; Mobasheri L; Montecucco F; Al-Rasadi K; Jamialahmadi T; Sahebkar A
Eur J Clin Invest; 2021 Jul; 51(7):e13534. PubMed ID: 33656763
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitors of HMG-CoA reductase in prevention of osteoporosis and bone fractures. Similar mechanism of action of statins and bisphosphonates].
Stajszczyk M; Mykała-Cieśla J
Pol Arch Med Wewn; 2002 Jan; 107(1):85-91. PubMed ID: 12046350
[No Abstract] [Full Text] [Related]
19. Hydroxymethylglutaryl-coenzyme A reductase inhibitors in osteoporosis management.
Coons JC
Ann Pharmacother; 2002 Feb; 36(2):326-30. PubMed ID: 11847956
[TBL] [Abstract][Full Text] [Related]
20. Statins and bone morphogenetic proteins: new pathways in bone formation.
Edwards CJ
Ann Acad Med Singap; 2002 Mar; 31(2):245-7. PubMed ID: 11957568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
